“Rapid Itch Relief with Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3b/4 Level Up Study”, J of Skin, vol. 10, no. 2, p. s735, Mar. 2026, doi: 10.25251/078a3s70.